MedPath

Prevention of stretch marks in pregnancy: a pilot trial

Not Applicable
Conditions
Striae gravidarum
Pregnancy and Childbirth
Registration Number
ISRCTN76992326
Lead Sponsor
ational University of Ireland Galway
Brief Summary

2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/30314504 2020 qualitative study of the factors influencing recruitment in https://www.ncbi.nlm.nih.gov/pubmed/32050916 (added 14/02/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped
Sex
Female
Target Recruitment
40
Inclusion Criteria

1. Primigravid women
2. Singleton pregnancy
3. 12-14 weeks gestation at time of recruitment; updated 13/07/2018: 12-16 weeks gestation at time of recruitment
4. Absence of abdominal striae
5. Aged 18 or over at recruitment
6. English speaking women

Exclusion Criteria

1. Multigravid women (due to risk of having striae from an earlier pregnancy)
2. Women taking corticosteroids for any reason (due to their association with skin striae)
3. Multiple pregnancy (due to increased maternal weight gain and skin stretching)
4. Women with a known hypersensitivity to agents in baby oil (due to risk of allergic reaction)
5. Women with known disorders or illnesses that may be associated with striae, e.g., Marfan syndrome, Cushing syndrome
6. Women who decline to discontinue other creams or lotions
7. Women who are unable to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath